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Executive summary and Recommendations
• Adolescence is the transitional phase of development
between childhood and adulthood.
• Health care and emotional needs are distinctly
different from younger children and older adults.
• It is important to understand the psychosocial
and physiological development of adolescence and
recognize that chronic diseases like diabetes have the
potential to inhibit life experiences (E).
• Many adolescents experience a deterioration in
metabolic control – attributable to the following:
◦ endocrine changes leading to increased insulin
resistance (B),
◦ erratic meal and exercise patterns (C),
◦ poor adherence to treatment regimens (C),
◦ eating disorders (C), and
◦ hazardous and risk-taking behaviors (C/E).
• Increase in weight gain, particularly in females may
be observed (C/E) provoking insulin omission to
effect weight loss (C).
• It is essential to develop appropriate communication
skills to facilitate teaching and education, and
recognize the need for privacy and confidentiality
for this age group (E).
• To-date, psychoeducation interventions have
demonstrated modest benefit on psychological
outcomes, but no effect on glycemic control (B/C).
• Recent randomized controlled trials of motivational
interviewing have shown no benefit in either
psychological measures or glycemic control (A).
• Developing a trusting and motivating relationship
between health care professionals and the adolescent
patient and maintaining continuity may result in
better patient self-care (C/D).
• Maintaining parental support and involvement
throughout adolescence is associated with better
outcomes (C/E).
• Identifying the need for specialized psychological
counseling may be helpful and can be facilitated
using specific screening tools (E).
• Providing health education opportunities utilizing
strategies that optimize self-care behavior and that
involve open-ended discussion, problem solving,
negotiated target setting, and the use of modern
technology are recommended (B/E).
• Education and advice on a variety of health care
matters, including employment, driving, alcohol,
drugs, sexual health, and contraception, should be
provided taking into account background cultural
and religious influences (E).
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• There should be no discrimination or stigma against
people with diabetes in the workplace (E).
• Organize regular screening for diabetes complica-
tions (E).
• Encourage understanding of the need for and imme-
diate benefits of improved metabolic control (E).
• Recognize the signs of mental health problems
(depression, eating disorders, illicit drug usage, etc.)
and the occasional need for psychiatric treatment
(E).
• Recognize that young people have differing views on
the appropriate age of transfer of their care to young
adult diabetes services (C/E).
• Planned coordinated transition to adult care should
be provided at the most appropriate time (E).
Adolescence is the transitional phase of development
between childhood and adulthood that incorporates
the biological and psychosocial changes of puberty.
It imposes unique challenges on the individual with
diabetes, their family, and the diabetes care team
(1, 2). Although the majority of adolescents adapt
well to the difficult challenges of puberty, it must
be recognized that their health care and emotional
needs are distinctly different from those of younger
children or older adults. Adolescence involves training
to become an independent adult and may result in
failures and mistakes as well as success.
In the context of type 1 diabetes many adolescents
experience a deterioration in metabolic control (3–6)
often attributable to erratic meal and exercise patterns
(7, 8), poor adherence to treatment regimens (9–12),
hazardous and risk-taking behaviors (1, 2, 13, 14),
eating disorders (15–20) and endocrine changes
associated with puberty, leading to greater insulin
resistance (21).
Changes in body habitus, particularly weight gain
in females (3, 5, 22–25) may be unwanted diabetes-
related side effects, sometimes associated with changes
in the tempo of pubertal maturation (25, 26) provoking
insulin omission to effect weight loss(12, 16, 18).
It is therefore recommended (1, 2, 27–32) that those
providing care for adolescents with diabetes should:
• Understand the psychosocial and physiological
development of adolescence (1, 2). This includes
the recognition of the need for young people
to shift (around the age of 10 yr onwards) from
‘concrete thinking’, with limited abstract capacity
for understanding time perspectives or consequences
of their actions, into adult cognitive capacity with
a more realistic perspective of the future, which is
achieved at a variable rate toward late adolescence
(33).
• Recognize that chronic conditions may inhibit some
young people from exploring life, while others
deliberately explore risk-taking behavior involving
their diabetes care.
• Develop communication skills [e.g., trusting, author-
authoritative (not authoritarian), allowing adequate
time, open questioning, patient-centered, observing
non-verbal messages and confidentiality].
• Understand that attending to the developmental
needs of young people may be just as important
for quality of life as diabetes specific treatment (34,
35).
• Recognize the intensity of the changing social
environment on behavior. Adolescents’ experience
a strong need to fit in and be accepted outside the
family – most importantly by peers.
• Acknowledge the emerging differences in lifestyle
and changing needs of adolescents. Exploring
various life styles is part of identity development and
includes experimentation in many domains, most
commonly in the company of peers.
• Identify the components of care unique to
adolescents.
• Provide planned transition to adult care at the most
appropriate time (35).
The weighted evidence base supporting these
recommendations has been recently reviewed in both
the Australian National Health and Medical Research
Council guidelines (30) and UK National Institute of
Clinical Excellence (NICE) guidelines (32).
Identifying the components of care that are
unique to adolescents
Most aspects of optimal care of adolescents with
diabetes have not been subjected to rigorous enquiry,
hence results are conflicting. Extensive review of psy-
choeducational interventions has concluded that they
may have modest benefit on psychological outcomes
but not on glycemic control, although the method-
ological quality of most studies was moderate to poor
(36, 37). Recent robustly designed randomized con-
trolled trials of motivational interviewing interventions
through training programs for pediatric diabetes teams
appear to lead to no improvement in either psychoso-
cial measures or hemoglobin A1c (HbA1c) levels (38).
Suggested care strategies might involve:
• Developing a trusting relationship between the
adolescent and the diabetes care team, including
through familiarity with staff and continuity in care
(1, 32, 39). Adolescents report better self-care when
health care professionals are motivating (1, 40).
• Helping the adolescent to clarify priorities and to set
small achievable targets particularly where there is
conflict between the needs of diabetes management
and the adolescent’s social development and peer
activities.
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Table 1. Parenting styles according to L. Steinberg (49)
and freely interpreted by K. Berg-Kelly 2007, personal
communication
Demanding Not demanding
Challenging Not challenging
Empathic with young
person
Authoritative Lenient Permissive
Non-empathic Authoritarian Unconcerned
Cold Rigid Neglectful Indifferent
• Providing well directed education to help understand
the physiological changes of puberty, their effect
on insulin dose, difficulties of weight control, and
dietary regulation.
• Organizing regular screening for early signs of com-
plications to encourage a practical understanding
of the options available and the immediate, long-
term and individual benefits of improved metabolic
control (35, 41).
• Recognizing the emerging maturity of the adolescent,
encouraging self-reliance and self-efficacy thus not
only allowing consultations to be increasingly
directed toward the adolescent but also retaining
the trust and support of parents (42).
• Helping the adolescent and parents to negotiate
new levels of parental involvement in diabetes care
tasks (35).
Emerging independence is best pursued gradually:
• Helping parents in their changing role from
full responsibility toward a gradual transition to
cooperative care with the adolescent. This role
change needs to be slow and gradual as continued
parental support and involvement in day to day
care is a strong determinant of improved clinical
outcomes. This is based on evidence that parental
support and involvement throughout adolescence is
associated with better outcomes (C, E) (1, 42–48).
• Identifying and advising on which parenting styles
are more likely to be successful than others [see
Table 1 and (49)].
The authoritative parent sets age-appropriate
demands respecting the maturity level and developmen-
tal needs, carefully explaining reasons for prohibiting
certain behaviors and agreeing on strategies for behav-
ior together with the young person in a respectful dia-
logue. The authoritative parent, however, does not bar-
gain about serious matters and has a clear goal of what
is important in the long run. Authoritative parents do
not need much support but need medical information.
The authoritarian, rigid parent gives orders, puts
his/her own ambitions first and does not consider needs
and feelings of the child. The rigid and demanding
families may need support to develop more adequate
parenting individually or in groups.
The lenient, permissive parents are highly empathetic
who seem to care too much about their children,
over-identify themselves with the needs of their children
and hate hurting them by getting into conflicts over
routines.
The unconcerned, neglectful, and indifferent parents
may have severe mental problems keeping them from
understanding and helping their children. Neglectful
parents require a careful social work-up to explore the
roots of dysfunction.
• Having an index of suspicion for signs of mental
health problems such as depression, eating disorders,
‘diabetes burnout’, illicit drug use, mental slowness,
attention deficit hyperactivity disorder (ADHD), and
neglectful or abusive family situations. Identifying
the need for, and effectiveness of, specialized
psychological counseling in some situations (50).
The HEADS technique (acronym for Home,
Education, Activities during spare time, Drugs and
Sexual activities) is helpful when screening for
psychosocial problems that might interfere with self-
management (51).
• Providing health education, utilizing strategies that
promote optimal health care behavior (see ISPAD
Guideline Chapters on Psychological Issues and
Education). Although there is consistent evidence
that knowledge per se is predictive of better self-care
and control this association is weak in adolescence
(1). Thus, while it is essential that adolescents are
provided with information about diabetes and its
care, providing this information by conventional
education alone may be insufficient to lead them to
adopt optimal health care.
• Encouraging the adolescent to participate with
parents and health care team members in making
decisions about diabetes management.
• Enabling the adolescent to learn from mistakes
without moral judgment.
• Offering a variety of educational opportunities
including open-ended adolescent-orientated discus-
sion and negotiation (52), discussing health-related
quality of life issues (53), problem solving, target
setting (50, 54), age-appropriate written materials,
CDs/videos, text messaging (55), the use of the
internet, social media, peer involvement, and group
learning.
• Facilitated meetings with peers who have diabetes in
order to receive advice, reflect and share experiences,
and reduce feelings of isolation (56).
Sub-optimal metabolic control
The Diabetes Control and Complications Trial
(DCCT) has unequivocally shown that intensive
insulin therapy reduces risk of long-term vascular
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complications, largely through improved HbA1c levels,
and that better metabolic control in the early years
of diabetes is also important in reducing this risk
(57, 58). Metabolic control commonly deteriorates
during adolescence, and this is partly due to
physiological influences. However, the health care team
should also consider the following:
• Socializing with peers is of utmost importance to
most adolescents which often conflicts with their
capacity to manage diabetes optimally.
• Adolescents with diabetes have the same needs for
exploration as other young people but studies have
shown that many of them are more vulnerable and
subjected to more pressures to conform to peer norms
(34, 35).
• Studies demonstrate slightly more involvement in
health hazardous behavior in those with chronic
conditions (14, 59).
• Adolescents may adopt non-demanding low risk
metabolic control by deliberately adjusting their
diabetes to a blood glucose level where they do
not risk hypoglycemia or hyperglycemia/ketonemia
and thus do not have their everyday life disturbed by
diabetes.
• Some adolescents, particularly female, may manipu-
late insulin doses or dietary habits in order to reduce
weight gain, which has the inevitable consequence
of worse metabolic control and increased vascular
complications risk (13).
• It may be helpful to negotiate from a cost-benefit
stand-point to assist the young person to understand
the short- and long-term costs of certain behaviors
as well as the potential benefits.
Severe hypoglycemia
Severe hypoglycemia may be experienced during
adolescence due to poor metabolic control, exacerbated
by irregularities of lifestyle and risk-taking behaviour.
In addition to the immediate effects on neurocognitive
function, evidence shows an important link between
severe hypoglycemia and preclinical atherosclerosis
and acute and chronic cardiovascular events in later
life (60, 61). This is relevant in the context of
intensive insulin therapy that may increase the risk of
severe hypoglycemia (62), although there is reassuring
new evidence that hypoglycemia may be reduced in
frequency by contemporary therapies (63) and careful
attention to detailed education (64–66).
Specific concerns during adolescence include:
• Development of hypoglycemic unawareness or
altered prodromal symptoms. An episode of severe
hypoglycemia may lead to a period of altered
awareness.
• Fears about hypoglycemia may be associated with
poorer metabolic control (67).
• Confusion with alcohol intoxication.
• Confusion with illicit drug effects.
• Nocturnal or early morning episodes due to altered
sleep patterns.
• The effect of hypoglycemia on driving.
• The effect of hypoglycemia on academic, sports, or
work performance.
Young people should be encouraged to understand
the benefits to them of better metabolic control.
Advice should be given about hypoglycemia to
enable adolescents to take positive measures in
recognizing, managing, and preventing hypoglycemia
(66, 68). Adolescents should be encouraged to inform
friends about the risks, symptoms, and treatment
of hypoglycemia during the altered routine of social
engagements (1).
Alcohol, smoking, and drugs
Alcohol, tobacco, and illicit drug use is a serious
concern in some communities during high school years
(69). Notwithstanding the paucity of evidence of the
variable contexts and type of alcohol consumption
in adolescents with diabetes (70), advice on alcohol,
smoking, and drugs should include:
• Encouragement to refrain from smoking and binge
drinking, and advice on avoiding the dangers of
drugs that may affect brain function or lead to
dependence or addiction.
• Adopting a realistic advisory approach to alcohol
rather than an absolute ban on medical grounds.
• Information on the effects of alcohol, particularly
in young adolescents, on the liver by inhibiting
gluconeogenesis with the possibility of either delayed
severe hypoglycemia. This can variably combine with
the carbohydrate content of the beverage to result in
an unpredictable glycemic response (71).
• Methods of avoiding nocturnal hypoglycemia after
drinking alcohol in the evening by ingesting
carbohydrate while drinking, maintenance of good
hydration, measuring blood glucose levels before
bedtime, and having carbohydrate before sleep to
minimize the risk of hypoglycemia.
• Ensuring that adolescents and their friends at parties
and events where alcohol is consumed, are aware
that hypoglycemia may occur when drinking alcohol
without eating; that vomiting, particularly with
omission of usual insulin, is dangerous and may be
inhaled or lead to ketoacidosis; that hypoglycemia
might be confused with intoxication and that it is
important to check blood glucose levels before sleep.
248 Pediatric Diabetes 2014: 15 (Suppl. 20): 245–256
Diabetes in adolescence
Providing information for and education of
colleagues or friends is increasingly important as the
young person develops independence from the family,
especially when living away from home at work,
college, or university.
• Authoritative, but empathic, advice about smoking
as an additional risk for the vascular complications
of diabetes (C) (72, 73).
• Helping the adolescent who does smoke to
stop by providing specific interventions that help
with smoking cessation (nicotine-patch, cognitive-
behavioral therapy, prescription drugs, etc.).
• Recognition that cannabis may alter eating habits
(excess snacking during and loss of appetite after
cannabis smoking) and may reduce motivation to
maintain good metabolic control.
• Illicit drugs may alter brain function, increasing
the risks of mistakes and mishaps with diabetes
management.
• Acknowledgment that a risk reduction policy may
be more realistic than an absolute ban on illicit drug
experimentation.
• Introduce strategies for managing stress during
adolescence other than medication, e.g., relaxation-
training, exercise, psychological evaluation for
anxiety or depression, hypnosis, etc.
Health care professionals should understand
that educational messages which are motivating,
problem solving, target setting, and which encourage
adolescents toward developing their own strategies to
avoid these problems are more successful than threats
or inducing fear (E) (1, 35).
Driving
Hypoglycemia is the main factor which increases
driving risk in people with diabetes (74), however,
this risk is mitigated in an individual with glycemic
awareness, stable metabolic control, and no visual
disability to the extent where they are able to drive
non-commercial vehicles (E) (75). Regulations vary
in different countries. Studies have variably shown
increased rates of driving accidents in drivers with
type 1 diabetes (T1D) (75–77). Studies have also
shown reductions in automobile accidents following
specific hypoglycemia awareness training programs (C)
(66–68).
The young person who plans to obtain a driving
licence should be advised on the appropriate
regulations and in particular:
• Prevention of hypoglycemia while driving (particu-
larly if hypoglycemic unawareness is a problem) by
blood glucose monitoring before starting to drive
and appropriate food intake (75).
• Encouraging stable metabolic control (particularly
avoidance of hypoglycemia) which may help
determine whether a person with diabetes is eligible
to hold a driving licence. Severe hypoglycemia in the
preceding months causes many authorities to delay
granting a licence.
• Regular visual acuity checks.
Employment
There should be no discrimination or stigma against
people with diabetes in the workplace (77, 78).
Most young people with diabetes should make good
employees because of their ability to organize their
lives and health care.
Advice on employment should include:
• Not concealing diabetes if asked about health
and encouraging young people to inform potential
employers about diabetes and how it is managed.
• The value of a good medical report from the diabetes
care team may reassure employers that diabetes
should not be a disadvantage in employment.
• Advice on those careers which may be unavailable
to persons with diabetes, e.g., police, fire, armed
and certain public services, driving large goods
vehicles, or piloting airplanes. New technological
developments may change these restrictions.
• Legal regulations vary between countries.
Reassurances to employers that young people with
diabetes make excellent employees if they have shown
mature self-care, self-discipline, and responsibility.
• Recommendations conclude that young people with
diabetes should be prepared for the work place in the
following ways:
◦ Be responsible for self care including monitoring of
blood glucose levels.
◦ Be careful to avoid significant hypoglycemia.
◦ Be candid about their diabetes to their employer.
◦ Have a physician report to potential employers
that supports the responsible diabetic young
person.
Sexual health
Advice to young people with regards to sexual health
will vary between different countries and cultures but
would usually include (79):
• A non-judgmental approach to sexual activity.
• Advice where applicable on methods of avoiding
pregnancy and sexually transmitted infections (STIs)
for male as well as female adolescents.
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• Prevention of hypoglycemia during or after
intercourse.
• Advice on genital hygiene, vulvovaginal candidiasis,
menstrual disorders, and STIs.
• Pre-pregnancy counseling
Adolescent girls with diabetes should be aware of
the importance of a planned pregnancy. Poor glycemic
control around the time of conception increases
the risks of congenital malformations, spontaneous
abortion, and fetal death (C) (79–84). Pre-pregnancy
counseling and education well in advance of the
possibility of pregnancy is advisable with emphasis on:
• Ovulation is preserved, even when poor metabolic
control and menstrual irregularities are present
(85–87).
• The importance of good glycemic control before
pregnancy, particularly the risks to the developing
embryo and fetus.
• Understanding the importance of good control
throughout pregnancy to avoid fetal macrosomia
and neonatal hypoglycemia and also the avoidance
of maternal hypoglycemia and ketoacidosis.
• Discussion with the young person and partner
regarding the genetic risks of diabetes to their
offspring.
Access to expert pregnancy management should
include:
• Cooperative management by an obstetrician and
physician with special experience in diabetes and
pregnancy.
• Delivery of the baby in a hospital able to provide
expert maternal, fetal, perinatal and neonatal care.
• Impotence
Males with long-standing diabetes may become
impotent because of autonomic neuropathy (C) (88).
Younger males may fear this complication and require
expert counseling. Impotence in adolescence is rare
and may be due to psychological reasons rather than
diabetes itself.
Contraception
The diabetes care team should be sensitive to
the religious and cultural influences affecting an
individual’s choice of contraceptive method (79).
• When a female with diabetes becomes sexually active
she should do so with knowledge of how to avoid an
unplanned pregnancy and STIs (E) (11, 12).
A planned pregnancy in a person with diabetes in
excellent metabolic control and in good health carries
risks that are slightly higher than those in the general
population, but not as elevated as previously reported
(C) (89–91).
Barrier methods.
• Worldwide safe sex, STIs and HIV campaigns have
made adolescents more aware of barrier methods,
particularly condoms.
• Condoms offer the greatest protection against STDs
to the whole genital tract (less against herpes), and
substantial protection against pregnancy.
• Diaphragms are not recommended for the adoles-
cent. Diaphragms are less effective contraception
than the condom and do not protect against vaginal
infection.
• Spermicidal gels probably increase the effectiveness
of barrier methods.
• Coitus interruptus, a common practice among
teenagers, is not recommended because it is
associated with a high pregnancy rate.
Hormonal contraception and oral contraceptives.
• In the past, oral contraceptives (OCs) with 50 μg
of ethinyl estradiol (EE) were thought to have
an adverse effect on metabolic control and lipid
profiles and increase the risks of hypertension,
cardiovascular, and thromboembolic diseases (C)
(79, 92, 93). Nowadays, OCs with 50 μg EE are
rarely used.
• Newer OCs with a lower estrogen dose (≤35 μg or
less EE) and newer progestogens have not been
demonstrated to be associated with detrimental
effects on metabolic control, weight, or lipid profile
(C) (79, 93–97).
• Young people with diabetes on OCs should be
monitored regularly, particularly blood pressure,
side effects such as headaches, mood changes, breast
changes, and genital infections.
• Patients without micro- or macro-vascular compli-
cations and diabetes duration <20 yr may use any
hormonal method (E) (98, 99).
• Patients with diabetes duration >20 yr, or having
micro- or macro-vascular complications should
avoid using OCs, but may use progestin only
methods, intrauterine device (IUD), or barrier
methods (E) (98, 99).
• Diabetes per se is not a risk factor of venous
thromboembolism (C) (100).
• All women taking OCs, including patients with
diabetes, should be educated on the signs of
thromboembolic diseases. Educate about clinical
signs of alert using the acronyms ACHES
(abdominal pain, chest pain, headaches, eye, and
severe leg pain).
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• Women with personal history of thrombotic disease
should not use combined hormonal contraception
(B) (98–101).
• If acne or hirsutism are a problem, the use of an
OC containing an anti-androgenic progestins may
be helpful (C) (102–104).
• Progesterone-only OCs may provide insufficient
contraception for teenagers who are likely to forget
the OCs.
• Similar to other adolescents without diabetes, in
some circumstances if there is the possibility of an
unwanted pregnancy it may be beneficial to advise
sexually active young people about the availability
of the ‘morning after’ hormone pill. No special
considerations for the adolescent with diabetes are
recommended in this setting (E) (105).
• Very obese patients should be aware of a decrease
of contraceptive efficacy of hormonal contraception
and higher risk of venous thromboembolism (C)
(106).
Depot hormone injections.
• Medroxyprogesterone injections have been associ-
ated with decreased bone mass gain, which may be
especially detrimental for the adolescent with T1D
(E).
• No studies have evaluated combined hormonal
monthly injection in patients with T1D, however,
this method may be of useful when the individual
has an erratic life style and is at high risk of pregnancy
(E).
Long acting reversible contraceptions.
• Recently, long acting reversible contraceptions
(LARCs), which include IUDs and the implantable
rod, have been accepted as a first line contraceptive
choice for nulliparous girls (E) (107, 108).
• IUDs provide no protection against STIs, but are
not associated with more episodes of STIs.
Study and examinations
Most adolescents will engage in a level of secondary
and/or tertiary education that will require some form
of formal assessment such as examinations. These may
be significant life events in that they will to varying
extent determine further educational and vocational
opportunities. Advice as to how a student may deal
with their diabetes to optimize academic performance
is frequently sought. Many students are well aware of
the cognitive effects of hypoglycemia (109, 110) and
thus may choose to run their glucose levels higher
than usual during exam times. They should however be
counseled as to the equally negative cognitive impacts
of hyperglycemia (111, 112). Glycemic responses
to exams may vary with individual students stress
responses, the type and length of the exam, and the
time of day. Consequently students should undertake
practice examinations in conditions that are as near as
possible to those that will be experienced in the actual
examination (i.e., same exam duration time, same time
of the day, etc). Blood glucose levels should be checked
immediately prior to and midway if a long exam (such
as 3 h). Adjustments to insulin regimens and/or diet can
then be made accordingly so as to maintain euglycemia
during the exam. As a general principle over the course
of the academic year, exercise should be encouraged to
reduce stress, improve physical fitness, improve sleep
patterns, and improve cognitive performance (113).
Transition from pediatric to adult services
The concept of transition implies a ‘planned,
purposeful movement of the adolescent or young
adult with a chronic disease from a child (and family)
centered to an adult orientated health care system’ (2).
The transition from a pediatric to an adult orientated
service should not involve a sudden unanticipated
transfer but an organized process of preparation
and adaptation. The process should be a component
of a high quality, multi-disciplinary diabetes service
(including the use of linked databases) and must involve
both teams of carers, an understanding of the two
different systems of care and the differing expectations
of those providing and those receiving care.
The appropriate age for transfer from a pediatric
or adolescent service to adult care varies according
to the maturity of the adolescent, the availability
of appropriate services for the young person in an
adult clinic and may be determined by hospital and
clinic facilities and regulations. Young people have
differing views on the appropriate age of transfer
(32–35, 114, 115). Recent developmental psychology
theory suggests that the transition should be toward
emerging adulthood and not to young adult status
(116). There is a potential danger that young people
become lost in the transition process and cease regular
attendance at the specialized service (C) (117). This
is likely to be associated with poor adherence to
treatment with increased risk of acute (12) and long-
term complications of diabetes including increased
mortality (C) (118). As no controlled studies have
been performed the following recommendations are
nearly all based on expert consensus opinion (E) (119).
For successful transition to an adult service, the
following steps should be considered:
• Identifying an adult service able to provide for the
needs of young adults with diabetes.
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• Providing a joint adolescent or young adult clinic
with members of both professional teams working
together to facilitate the transition process for both
adolescents and their parents.
• Liaison between the pediatric and adult services.
Ideally this should involve identifying a specific
person in the service (a ‘key worker’) who is able
to move between both services to help the transition
of the young person into the adult service. There is
evidence that the appointment of a specialist nurse
for adolescence has been successful in this role (C)
(120). If such a person is not available, one of the
pediatric staff should take responsibility for liaison
with the adult service and both groups must have
understanding of the services involved.
• Discussion with the adolescent and parent well in
advance as to the best time for transfer, based on not
only their own preference and readiness, but also on
the availability of services and, in some countries,
health care insurance requirements. It is preferable
to have flexibility about age of transition as family
circumstances and an adolescent’s psychosocial
maturity differ widely.
• Development of clear, documented plans for
transition services, and provision of a clinical
summary of the young person’s medical history
including indices of control, the results of
complication screening and information on any
comorbidities that may impact on how the person is
managed medically.
• Good communication, including a written patient
care pathway and protocol (30–32, 35), to facilitate
understanding between all services providing care
for the young person, particularly all members of the
two diabetes teams and including, where available,
primary care physicians and community nursing
staff.
• Ensuring that there is no significant gap in care
between leaving the pediatric service and entering
the adult service and that the young person is not
lost to follow-up care (35). This may occur if the
young person fails to make or keep an appointment,
or feels uncomfortable in the new service and loses
touch with a specific named team member.
• The diabetes transition service should have
mechanisms in place, including a database and a
named professional, to identify and locate all young
people who fail to attend follow-up consultations.
The adult service should be strongly encouraged
to ensure long-term follow-up and outcome measure-
ments of those who have developed diabetes as children
and adolescents as many studies show poor glycemic
control and longer term morbidities (C) (121, 122).
To date there have been very few robust studies
investigating best models of transition to adult care
services (123). Several trials are currently underway
attempting to address this lack of evidence base (124).
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